中国医学创新Issue(31)：134-135,2.DOI:10.3969/j.issn.1674-4985.2013.31.062
热毒宁与利巴韦林联合应用治疗小儿手足口病的临床优势分析
The Analysis of the Clinical Advantages of Reduning Combined with Ribavirin in Treatment of Children with Hand Foot and Mouth Disease
刘忠琼1
作者信息
- 1. 云南省曲靖市会泽县人民医院分院 云南 会泽 654211
- 折叠
摘要
Abstract
Objective:To analyze the clinical advantages of reduning combined with ribavirin in the treatment of children with hand-foot-mouth disease.Method:The clinical data of 56 children with hand foot and mouth disease in the hospital were retrospectively analyzed. They were divided into the treatment group and the control group,28 cases in each group.The control group was treated with ribavirin,and the treatment group was taken with Reduning on the basis of ribavirin.The clinical efficacy and the incidence of adverse reactions of the two groups were compared.Result:After treatment, the total effective rate of treatment group(92.86%)was significantly higher than the control group(82.14%,P<0.05).The cure rate was significant difference between treatment group(42.85%)and control group(32.14%,P<0.05).And the incidence rate of adverse reaction was significant difference between the two groups(P<0.05),which in the treatment group was 7.14%and in the control group was 14.28%.Conclusion:Reduning combined with ribavirin in the treatment of children with hand foot and mouth disease is with high safety,and the clinical curative effect is significant.关键词
热毒宁/利巴韦林/小儿手足口病/临床优势Key words
Reduning/Ribavirin/Children with hand foot and mouth disease/Clinical advantage引用本文复制引用
刘忠琼..热毒宁与利巴韦林联合应用治疗小儿手足口病的临床优势分析[J].中国医学创新,2013,(31):134-135,2.
